SIÇANLARDA TRANEKSAMİK ASİDİN KOAGÜLASYON VE FLEP SAĞKALIMI ÜZERİNE ETKİLERİ

Öz

Amaç: Traneksamik asit (TNA), perioperatif kan kaybını azaltmak için kullanılan bir antifibrinolitiktir. Çalışmamızda sıçan üzerinde kaldırılan random (rastgele) fleplerde TNA’nın flep nekroz oranı üzerine etkileri incelendi. Bu yolla TNA’nın flep cerrahisi açısından güvenilirliğini sınamak amaçlandı. Gereç ve Yöntem: Çalışmada 14 adet Sprague-Dawley cinsi erkek sıçan kullanıldı. Sıçanlar her grupta yedi sıçan olacak şekilde rastgele iki gruba ayrıldı. Deneyin ilk aşamasında standardize bir “kuyruk kanama modeli” kullanılarak kanamanın durmasına kadar geçen zamanı ölçüldü. Ardından deney grubuna 100 mg/ kg dozunda TNA, kontrol grubuna ise eşit hacimde %0,9 NaCl enjekte edildi ve kanama zamanı ve kanama miktarı ölçümleri tekrarlandı. Sıçanlar operasyon sonrası yedinci günde sakrifiye edilerek flepteki nekroz alanı ölçüldü. Bulgular: TNA verilen sıçanlarda kanama zamanı, ilaç verilmesi öncesinde yapılan kanama zamanı ölçümüne göre istatistiksel olarak anlamlı ölçüde kısa bulundu. Kontrol grubunda ise bu şekilde bir fark izlenmedi. İki grup arasında flep nekroz oranı açısından anlamlı bir fark bulunmadı. Sonuç: Yaptığımız deneysel çalışmada TNA’nın flep sağkalımı üzerine olumsuz bir etkisinin olmadığı görülmüştür.

Anahtar Kelimeler

• Pediküllü flep,Traneksamik asit

EFFECTS OF TRANEXAMIC ACID ON COAGULATION AND FLAP SURVIVAL IN RATS

Öz

Objective: Tranexamic acid (TNA) is an antifibrinolytic agent which is used to decrease blood loss during surgery. In our study, we investigated the effects of TNA on the extent of flap necrosis using random flaps in rats. Our aim was to test the safety of TNA within flap surgery. Material and Method: Fourteen male Sprague-Dawley rats were used. The rats were randomly divided into two groups with 7 rats in each group. For the first stage of the experiment, a “rat tail bleeding model” was used to measure time taken to stop bleeding. The measurement of bleeding time was repeated after an injection of 100 mg/kg TNA in the study group and 0.9% NaCl in the control group in equal volumes. The rats were sacrificed on the seventh postoperative day and the area of necrosis was measured. Results: The bleeding time became shorter in rats after the administration of TNA, while no such effect was observed in the control group. There was no difference between the two groups regarding the flap necrosis ratio. Conclusion: Our study shows that TNA administration does not have a negative effect on random flap survival in rats.

Anahtar Kelimeler

• Pedicled flap,Tranexamic Acid,Surgical blood loss

Kaynakça

1. 1. Hjortdal VE, Sinclair T, Kerrigan CL, Solymoss S. Arterial ischemia in skin flaps: microcirculatory intravascular thrombosis. Plast Reconstr Surg 1994;93(2):375-85.
2. 2. Clerc M, Prothet J, Rimmele T. Perioperative management of a bilateral forearm allograft. Hand Surg Rehabil 2016;35(3):215-9.
3. 3. Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, et al. Tranexamic Acid in Patients Undergoing CoronaryArtery Surgery. N Engl J Med 2017;376(2):136-48.
4. 4. Ker K, Roberts I, Shakur H, Coats TJ. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2015(5):CD004896.
5. 5. McNicol ED, Tzortzopoulou A, Schumann R, Carr DB, Kalra A. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev 2016;9:CD006883.
6. 6. Valerio IL, Campbell P, Sabino J, Lucas DJ, Jessie E, Rodriguez C, et al. TXA in combat casualty care--does it adversely affect extremity reconstruction and flap thrombosis rates? Mil Med 2015;180(3 Suppl):24-8.
7. 7. Collaborators CT, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010;376(9734):23-32.
8. 8. Sperzel M, Huetter J. Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation. J Thromb Haemost 2007;5(10):2113-8.

9. 9. Ryan KL, Cortez DS, Dick EJ, Jr., Pusateri AE. Efficacy of FDA-approved hemostatic drugs to improve survival and reduce bleeding in rat models of uncontrolled hemorrhage. Resuscitation 2006;70(1):133-44.
10. 10. McFarlane RM, Deyoung G, Henry RA. The Design of a Pedicle Flap in the Rat to Study Necrosis and Its Prevention. Plast Reconstr Surg 1965;35:177-82.
11. 11. Collaborators WT. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017;389(10084):2105-16.
12. 12. Akçora B, Altuğ M, Öztürk A, Özer C. Dalak Laserasyonu Oluşturulmuş Sıçanlarda Traneksamik Asit’in Kanama Miktarı Üzerindeki Etkileri. Journal of Experimental and Clinical Medicine 2009;26:169-72.
13. 13. Li G, Sun TW, Luo G, Zhang C. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis. Eur Spine J 2017;26(1):14054. [CrossRef] 14. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999;57(6):1005-32.
14. 15. Hum IL, Fisher JC, Arganese T, Rudolph R. Standardization of the Dorsal Rat Flap Model. Ann Plast Surg 1983;11(3):2103.
15. 16. Vinckier F, Vermylen J. Wound healing following dental extractions in rabbits: effects of tranexamic acid, warfarin anti-coagulation, and socket packing. J Dent Res 1984;63(5):646-9.
16. 17. Lardi AM, Dreier K, Junge K, Farhadi J. The use of tranexamic acid in microsurgery-is it safe? Gland Surg 2018;7(Suppl 1):S59-S63.
17. 18. Henry DA, Carless PA, Moxey AJ, O’Connell D, Stokes BJ, Fergusson DA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011(1):CD001886.
18. 19. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012;344:e3054